The ameliorative effect of cysteine prodrug L-2-oxothiazolidine-4- carboxylic acid on cisplatin-induced nephrotoxicity in rats

Fundamental and Clinical Pharmacology

Volumn 21, Issue 5, 2007, Pages 547-553

  Ali, B H ^a   Al Moundhri, M S ^a   Tag Eldin, M ^a   Nemmar, A ^b   Tanira, M O ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Cisplatin; L 2 oxothiazolidine 4 carboxylic acid; Nephrotoxicity; Rats

Indexed keywords

2 OXO 4 THIAZOLIDINECARBOXYLIC ACID; CISPLATIN; CREATININE; CYSTEINE; GLUTATHIONE; N ACETYL BETA GLUCOSAMINIDASE; PRODRUG; PROTEIN; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG TISSUE LEVEL; ENZYME ACTIVITY; ENZYME INHIBITION; HISTOPATHOLOGY; KIDNEY; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY NECROSIS; KIDNEY PROXIMAL TUBULE; MICROSCOPY; NEPHROTOXICITY; NONHUMAN; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; SINGLE DRUG DOSE; TISSUE LEVEL; UREA BLOOD LEVEL; URINALYSIS; URINE OSMOLALITY; URINE VOLUME;

ACETYLGLUCOSAMINIDASE; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; CREATININE; GLUTATHIONE; KIDNEY CORTEX; KIDNEY DISEASES; MALE; OSMOLAR CONCENTRATION; PRODRUGS; PYRROLIDONECARBOXYLIC ACID; RANDOM ALLOCATION; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIAZOLIDINES; UREA;

EID: 34548629477     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2007.00495.x     Document Type: Article

References (24)

1. Markman M. Toxicities of the platinum antineoplastic agents. Expert Opin. Drug Saf. (2003) 2 597 607.
2. Zhang L., Cooper A.J., Krasnikov B.F. et al. Cisplatin-induced toxicity is associated with platinum deposition in mouse kidney mitochondria in vivo and with selective inactivation of the alpha-ketoglutarate dehydrogenase complex in LLC-PK1 cells. Biochemistry (2006) 45 8959 8971.
3. Boulikas T., Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol. Rep. (2003) 10 663 682.
4. Taguchi T., Nazneen A., Abid M.R., Razzaque M.S. Cisplatin-associated nephrotoxicity and pathological events. Contrib. Nephrol. (2005) 148 107 121.
5. Ramesh G., Reeves W.B. Inflammatory cytokines in acute renal failure. Kidney Int. Suppl. (2004) 91 S56 S61.
6. Hartmann J.T., Lipp H.P. Toxicity of platinum compounds. Expert Opin. Pharmacother. (2003) 4 889 901.
7. Sogut S., Kotuk M., Yilmaz H.R., Ulu R., Ozyurt H., Yildirim Z. In vivo evidence suggesting a role for purine-catabolizing enzymes in the pathogenesis of cisplatin-induced nephrotoxicity in rats and effect of erdosteine against this toxicity. Cell Biochem. Funct. (2004) 22 57 62.
8. Saleh S., El-Demerdash E. Protective effects of l-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide. Basic Clin. Pharmacol. Toxicol. (2005) 97 91 97.
9. Bhat S.G., Mishra S., Mei Y. et al. Cisplatin up-regulates the adenosine A (1) receptor in the rat kidney. Eur. J. Pharmacol. (2002) 442 51 64.
10. Cetin R., Devrim E., Kilicoglu B., Avci A., Candir O., Durak I. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods. J. Appl. Toxicol. (2006) 26 2 6.
11. Ali B.H., Al Moundhri M.S. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food Chem. Toxicol. (2006) 44 173 183.
12. Williamson J.M., Meister A. Stimulation of hepatic glutathione formation by administration of l-2-oxothiazolidine-4-carboxylate, a 5-oxo-l-prolinase substrate. Proc. Natl Acad. Sci. U.S.A. (1981) 78 36 39.
13. Mesina J.E., Page R.H., Hetzel F.W., Chopp M. Administration of l-2-oxothiazolidine-4-carboxylate increases glutathione levels in rat brain. Brain Res. (1989) 478 181 183.
14. Dickey D.T., Wu Y.J., Muldoon L.L., Neuwelt E.A. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J. Pharmacol. Exp. Ther. (2005) 314 1052 1058.
15. Wu Y.J., Muldoon L.L., Neuwelt E.A. The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway. J. Pharmacol. Exp. Ther. (2005) 312 424 431.
16. Lee S., Moon S.O., Kim W. et al. Protective role of l-2-oxothiazolidine- 4-carboxylic acid in cisplatin-induced renal injury. Nephrol. Dial. Transplant. (2006) 21 2085 2095.
17. Sedlak J.I., Lindsay R.H. Estimation of total protein-bound and non-protein bound sulphydryl groups in tissues with Ellman's reagent. Anal. Biochem. (1968) 25 192 205.
18. Mohan I.K., Khan M., Shobha J.C. et al. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats. Cancer Chemother. Pharmacol. (2006) 58 208 808.
19. Naziroglu M., Karaoglu A., Aksoy A.O. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology (2004) 195 221 230.
20. Hanigan M.H., Devarajan P. Cispaltin nephrotoxicity: molecular mechanisms. Cancer Ther. (2003) 1 47 61.
21. Park S.J., Lee Y.C. Antioxidants as novel agents for asthma. Mini Rev. Med. Chem. (2006) 6 235 240.
22. Arany I., Safirstein R.L. Cisplatin nephrotoxicity. Sem. Nephrol. (2003) 23 460 464.
23. Nishikawa M., Nagatomi H., Nishijima M. et al. Targeting superoxide dismutase to renal proximal tubule cells inhibits nephrotoxicity of cisplatin and increases the survival of cancer-bearing mice. Cancer Lett. (2001) 171 133 138.
24. Henderson W.R. Jr., Chi E.Y., Teo J.L., Nguyen C., Kahn M. A small molecule inhibitor of redox-regulated NF-kappa B and activator protein-transcription blocks allergic airway inflammation in a mouse asthma model. J. Immunol. (2002) 169 5294 5299.